Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-12-13 Sale |
2021-12-15 5:08 pm |
Kronos Bio Inc. | KRON | Dinsmore Christopher Chief Scientific Officer |
11,386 | $12.37 | $140,845 | 84,974 (Direct) |
View |
| 2021-12-13 Sale |
2021-12-15 5:06 pm |
Kronos Bio Inc. | KRON | DiMartino Jorge Chief Medical Officer & VP |
16,402 | $12.37 | $202,893 | 117,535 (Direct) |
View |
| 2021-12-06 Purchase |
2021-12-08 6:21 pm |
Kronos Bio Inc. | KRON | BISCHOFBERGER NORBERT W President & CEO |
14,356 | $12.09 | $173,492 | 5,637,976 (Indirect Direct) |
View |
| 2021-12-01 Purchase |
2021-12-02 5:12 pm |
Kronos Bio Inc. | KRON | De Backer Marianne Director |
1,150 | $11.57 | $13,306 | 2,750 (Direct) |
View |
| 2021-10-04 Sale |
2021-10-04 6:24 pm |
Kronos Bio Inc. | KRON | Dinsmore Christopher Chief Scientific Officer |
9,189 | $20.81 | $191,195 | 411,668 (Direct) |
View |
| 2021-09-07 Sale |
2021-09-09 1:23 pm |
Kronos Bio Inc. | KRON | Dinsmore Christopher Chief Scientific Officer |
9,189 | $21.91 | $201,302 | 420,857 (Direct) |
View |
| 2021-08-20 Purchase |
2021-08-24 7:24 pm |
Kronos Bio Inc. | KRON | De Backer Marianne Director |
1,000 | $19.57 | $19,565 | 1,600 (Direct) |
View |
| 2021-08-02 Sale |
2021-08-03 5:13 pm |
Kronos Bio Inc. | KRON | Dinsmore Christopher Chief Scientific Officer |
9,189 | $20.59 | $189,165 | 430,046 (Direct) |
View |
| 2021-05-28 Purchase |
2021-06-01 4:08 pm |
Kronos Bio Inc. | KRON | De Backer Marianne Director |
600 | $25.01 | $15,006 | 600 (Direct) |
View |
| 2021-04-16 Sale |
2021-04-20 6:59 pm |
Kronos Bio Inc. | KRON | Loven Jakob Director |
68,717 | $20.64 | $1,418,226 | 1,301,537 (Indirect) |
View |
| 2021-04-13 Sale |
2021-04-15 6:57 pm |
Kronos Bio Inc. | KRON | Loven Jakob Director |
74,474 | $22.7 | $1,690,359 | 1,370,254 (Indirect) |
View |
| 2021-04-08 Sale |
2021-04-12 8:33 pm |
Kronos Bio Inc. | KRON | Loven Jakob Director |
100,616 | $27.19 | $2,735,534 | 1,444,728 (Indirect) |
View |
| 2020-10-14 Purchase |
2020-10-16 3:58 pm |
Kronos Bio Inc. | KRON | Omega Fund V L.P. Omega Fund V GP L.P. Omega Fund V GP Manager Ltd. Paster Anne-Mari Nessi Claudio Stampacchia Otello 10% Owner |
450,000 | $19 | $8,550,000 | 3,818,283 (Direct) |
View |
| 2020-10-14 Purchase |
2020-10-16 3:56 pm |
Kronos Bio Inc. | KRON | Stampacchia Otello Director 10% Owner |
450,000 | $19 | $8,550,000 | 3,818,283 (Indirect) |
View |
| 2020-10-14 Purchase |
2020-10-16 3:52 pm |
Kronos Bio Inc. | KRON | Ridloff Elena Director |
2,630 | $19 | $49,970 | 2,630 (Direct) |
View |
| 2020-10-14 Purchase |
2020-10-16 3:51 pm |
Kronos Bio Inc. | KRON | MARTIN JOHN C Director |
75,800 | $19 | $1,440,200 | 1,952,364 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-02-15 Option Award |
2022-02-17 5:23 pm |
N/A 2032-02-14 |
Kronos Bio Inc. | KRON | Kosacz Barbara COO & General Counsel |
133,600 | $0 | 818,024 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 5:22 pm |
N/A 2032-02-14 |
Kronos Bio Inc. | KRON | DiMartino Jorge Chief Medical Officer & VP |
150,300 | $0 | 267,835 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 5:21 pm |
N/A 2032-02-14 |
Kronos Bio Inc. | KRON | Dinsmore Christopher Chief Scientific Officer |
108,550 | $0 | 193,524 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 5:19 pm |
N/A 2032-02-14 |
Kronos Bio Inc. | KRON | Al-Wakeel Yasir B. Chief Financial Officer |
133,600 | $0 | 243,241 (Direct) |
View |
| 2021-11-11 Option Award |
2021-11-15 1:45 pm |
N/A 2031-11-10 |
Kronos Bio Inc. | KRON | Blunt Roshawn A. Director |
41,200 | $0 | 41,200 (Direct) |
View |
| 2021-10-04 Exercise |
2021-10-04 6:24 pm |
N/A 2030-06-14 |
Kronos Bio Inc. | KRON | Dinsmore Christopher Chief Scientific Officer |
9,189 | $0 | 411,668 (Direct) |
View |
| 2021-10-04 Exercise |
2021-10-04 6:24 pm |
N/A N/A |
Kronos Bio Inc. | KRON | Dinsmore Christopher Chief Scientific Officer |
9,189 | $3.27 | 411,668 (Direct) |
View |
| 2021-09-07 Exercise |
2021-09-09 1:23 pm |
N/A 2030-06-14 |
Kronos Bio Inc. | KRON | Dinsmore Christopher Chief Scientific Officer |
9,189 | $0 | 420,857 (Direct) |
View |
| 2021-09-07 Exercise |
2021-09-09 1:23 pm |
N/A N/A |
Kronos Bio Inc. | KRON | Dinsmore Christopher Chief Scientific Officer |
9,189 | $3.27 | 420,857 (Direct) |
View |
| 2021-08-02 Exercise |
2021-08-03 5:13 pm |
N/A 2030-06-14 |
Kronos Bio Inc. | KRON | Dinsmore Christopher Chief Scientific Officer |
9,189 | $0 | 430,046 (Direct) |
View |
| 2021-08-02 Exercise |
2021-08-03 5:13 pm |
N/A N/A |
Kronos Bio Inc. | KRON | Dinsmore Christopher Chief Scientific Officer |
9,189 | $3.27 | 430,046 (Direct) |
View |
| 2021-06-22 Option Award |
2021-06-23 9:22 pm |
N/A 2031-06-21 |
Kronos Bio Inc. | KRON | Yang Taiyin Director |
5,150 | $0 | 5,150 (Direct) |
View |
| 2021-06-22 Option Award |
2021-06-23 9:21 pm |
N/A 2031-06-21 |
Kronos Bio Inc. | KRON | De Backer Marianne Director |
8,583 | $0 | 8,583 (Direct) |
View |
| 2021-06-22 Option Award |
2021-06-23 9:20 pm |
N/A 2031-06-21 |
Kronos Bio Inc. | KRON | Ridloff Elena Director |
15,450 | $0 | 15,450 (Direct) |
View |
| 2021-06-22 Option Award |
2021-06-23 9:18 pm |
N/A 2031-06-21 |
Kronos Bio Inc. | KRON | Stampacchia Otello Director 10% Owner |
20,600 | $0 | 20,600 (Direct) |
View |
| 2021-06-22 Option Award |
2021-06-23 9:16 pm |
N/A 2031-06-21 |
Kronos Bio Inc. | KRON | Kazam Joshua A Director |
20,600 | $0 | 20,600 (Direct) |
View |
| 2021-06-22 Option Award |
2021-06-23 9:14 pm |
N/A 2031-06-21 |
Kronos Bio Inc. | KRON | Belldegrun Arie Director |
20,600 | $0 | 20,600 (Direct) |
View |
| 2021-06-22 Option Award |
2021-06-23 9:12 pm |
N/A 2031-06-21 |
Kronos Bio Inc. | KRON | TANEN DAVID M Director |
20,600 | $0 | 20,600 (Direct) |
View |
Ownership(A) |
2021-04-28 2:14 pm |
N/A N/A |
Kronos Bio Inc. | KRON | BISCHOFBERGER NORBERT W President & CEO |
0 | $0 | 2,121,159 (Indirect) |
View |
| 2021-03-25 Option Award |
2021-03-26 1:41 pm |
N/A 2031-03-24 |
Kronos Bio Inc. | KRON | Yang Taiyin Director |
41,200 | $0 | 41,200 (Direct) |
View |
| 2021-01-25 Option Award |
2021-01-27 5:03 pm |
N/A N/A |
Kronos Bio Inc. | KRON | De Backer Marianne Director |
41,200 | $0 | 41,200 (Direct) |
View |
| 2020-12-10 Option Award |
2020-12-11 4:41 pm |
N/A 2030-12-09 |
Kronos Bio Inc. | KRON | BISCHOFBERGER NORBERT W President & CEO |
495,310 | $0 | 5,920,806 (Direct) |
View |
| 2020-12-09 Option Award |
2020-12-11 4:35 pm |
N/A 2030-12-08 |
Kronos Bio Inc. | KRON | Kosacz Barbara COO & General Counsel |
174,560 | $0 | 789,160 (Direct) |
View |
| 2020-12-09 Option Award |
2020-12-11 4:34 pm |
N/A 2030-12-08 |
Kronos Bio Inc. | KRON | Dinsmore Christopher Chief Scientific Officer |
227,775 | $0 | 233,025 (Direct) |
View |
| 2020-12-09 Option Award |
2020-12-11 4:32 pm |
N/A 2030-12-08 |
Kronos Bio Inc. | KRON | DiMartino Jorge Chief Medical Officer & VP |
334,843 | $0 | 334,843 (Direct) |
View |
| 2020-12-09 Option Award |
2020-12-11 4:30 pm |
N/A 2030-12-08 |
Kronos Bio Inc. | KRON | Al-Wakeel Yasir B. Chief Financial Officer |
181,055 | $0 | 218,274 (Direct) |
View |
| 2020-10-14 Conversion |
2020-10-16 3:58 pm |
N/A N/A |
Kronos Bio Inc. | KRON | Omega Fund V L.P. Omega Fund V GP L.P. Omega Fund V GP Manager Ltd. Paster Anne-Mari Nessi Claudio Stampacchia Otello 10% Owner |
366,299 | $16.15 | 3,818,283 (Direct) |
View |
| 2020-10-14 Conversion |
2020-10-16 3:58 pm |
N/A N/A |
Kronos Bio Inc. | KRON | Omega Fund V L.P. Omega Fund V GP L.P. Omega Fund V GP Manager Ltd. Paster Anne-Mari Nessi Claudio Stampacchia Otello 10% Owner |
11,725,310 | $0 | 3,818,283 (Direct) |
View |
| 2020-10-14 Conversion |
2020-10-16 3:56 pm |
N/A N/A |
Kronos Bio Inc. | KRON | Stampacchia Otello Director 10% Owner |
366,299 | $16.15 | 3,818,283 (Indirect) |
View |
| 2020-10-14 Conversion |
2020-10-16 3:56 pm |
N/A N/A |
Kronos Bio Inc. | KRON | Stampacchia Otello Director 10% Owner |
11,725,310 | $0 | 3,818,283 (Indirect) |
View |
| 2020-10-14 Conversion |
2020-10-16 3:54 pm |
N/A N/A |
Kronos Bio Inc. | KRON | TANEN DAVID M Director |
37,119 | $16.15 | 913,783 (Indirect) |
View |
| 2020-10-14 Conversion |
2020-10-16 3:54 pm |
N/A N/A |
Kronos Bio Inc. | KRON | TANEN DAVID M Director |
1,639,224 | $0 | 913,783 (Direct) |
View |
| 2020-10-14 Conversion |
2020-10-16 3:51 pm |
N/A N/A |
Kronos Bio Inc. | KRON | MARTIN JOHN C Director |
205,260 | $16.15 | 1,952,364 (Indirect) |
View |
| 2020-10-14 Conversion |
2020-10-16 3:51 pm |
N/A N/A |
Kronos Bio Inc. | KRON | MARTIN JOHN C Director |
6,570,443 | $0 | 1,952,364 (Indirect) |
View |